127 related articles for article (PubMed ID: 30431724)
1. Comparison of Different Diagnostic Guidelines for the Diagnosis of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: Single Centre Experience.
Jelušić M; Kronja M; Frković M; Sršen S; Huljev Frković S; Štekić Novački K
Acta Clin Croat; 2018 Jun; 57(2):307-311. PubMed ID: 30431724
[TBL] [Abstract][Full Text] [Related]
2. [Clinical characteristics and diagnostic indicators of macrophage activation syndrome in patients with systemic lupus erythematosus and adult-onset Still's disease].
Yao HH; Yang F; Tang SM; Zhang X; He J; Jia Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):966-974. PubMed ID: 38101776
[TBL] [Abstract][Full Text] [Related]
3. Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Boom V; Anton J; Lahdenne P; Quartier P; Ravelli A; Wulffraat NM; Vastert SJ
Pediatr Rheumatol Online J; 2015 Dec; 13():55. PubMed ID: 26634252
[TBL] [Abstract][Full Text] [Related]
4. Single center clinical analysis of macrophage activation syndrome complicating juvenile rheumatic diseases.
Huang S; Liu Y; Yan W; Zhang T; Wang P; Zhu M; Zhang X; Zhou P; Fan Z; Yu H
Pediatr Rheumatol Online J; 2024 May; 22(1):58. PubMed ID: 38783316
[TBL] [Abstract][Full Text] [Related]
5. Is it possible to predict a disease course prone to macrophage activation syndrome at systemic juvenile idiopathic arthritis diagnosis?
Batu ED; Sener S; Balık Z; Bayındır Y; Cam V; Kasap Cuceoglu M; Uysal O; Aliyev E; Basaran Ö; Bilginer Y; Özen S
Clin Rheumatol; 2024 Jan; 43(1):415-421. PubMed ID: 38012469
[TBL] [Abstract][Full Text] [Related]
6. Complications of complications: diagnosis and treatment of recurrent macrophage activation syndrome in a patient with well-controlled systemic juvenile idiopathic arthritis.
Macaraeg M; Schulert GS
RMD Open; 2023 Jan; 9(1):. PubMed ID: 36690384
[TBL] [Abstract][Full Text] [Related]
7. Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature.
Sönmez HE; Demir S; Bilginer Y; Özen S
Clin Rheumatol; 2018 Dec; 37(12):3329-3335. PubMed ID: 29663156
[TBL] [Abstract][Full Text] [Related]
8. Population Pharmacokinetics of the Anti-Interferon-Gamma Monoclonal Antibody Emapalumab: An Updated Analysis.
Brossard P; Laveille C
Rheumatol Ther; 2024 Jun; 11(3):869-880. PubMed ID: 38662147
[TBL] [Abstract][Full Text] [Related]
9. Performance of interferon-gamma levels may lead to earlier diagnosing macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
Lu M; Teng L; Xu Y; Xu X
Pediatr Rheumatol Online J; 2023 Oct; 21(1):115. PubMed ID: 37828529
[TBL] [Abstract][Full Text] [Related]
10. Prolonged Fever in a Pediatric Patient: A Case of Systemic Juvenile Idiopathic Arthritis (sJIA) Complicated by Macrophage Activation Syndrome (MAS).
Cortes M; Nudelman BG; Rouse MJ; Frost MD
Cureus; 2023 Sep; 15(9):e46083. PubMed ID: 37900539
[TBL] [Abstract][Full Text] [Related]
11. Systemic juvenile idiopathic arthritis-associated lung disease: A retrospective cohort study.
Belozerov KE; Solomatina NM; Isupova EA; Kuznetsova AA; Kostik MM
World J Clin Pediatr; 2024 Mar; 13(1):88912. PubMed ID: 38596441
[TBL] [Abstract][Full Text] [Related]
12. A rare case of coronary artery complication in a child with systemic juvenile idiopathic arthritis and macrophage activation syndrome: case report and literature review.
Zhang L; Wei Y; Zeng N; Wang L; Chen X; Yang J; Xiao X
Pediatr Rheumatol Online J; 2024 Jan; 22(1):4. PubMed ID: 38166957
[TBL] [Abstract][Full Text] [Related]
13. Treatment of systemic juvenile idiopathic arthritis.
Hinze CH; Foell D; Kessel C
Nat Rev Rheumatol; 2023 Dec; 19(12):778-789. PubMed ID: 37923864
[TBL] [Abstract][Full Text] [Related]
14. An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome.
Taylor ML; Hoyt KJ; Han J; Benson L; Case S; Chandler MT; Chang MH; Platt C; Cohen EM; Day-Lewis M; Dedeoglu F; Gorman M; Hausmann JS; Janssen E; Lee PY; Lo J; Priebe GP; Lo MS; Meidan E; Nigrovic PA; Roberts JE; Son MBF; Sundel RP; Alfieri M; Yeun JC; Shobiye DM; Degar B; Chang JC; Halyabar O; Hazen MM; Henderson LA
J Rheumatol; 2022 Sep; 49(9):1042-1051. PubMed ID: 35840156
[TBL] [Abstract][Full Text] [Related]
15. Emergent high fatality lung disease in systemic juvenile arthritis.
Saper VE; Chen G; Deutsch GH; Guillerman RP; Birgmeier J; Jagadeesh K; Canna S; Schulert G; Deterding R; Xu J; Leung AN; Bouzoubaa L; Abulaban K; Baszis K; Behrens EM; Birmingham J; Casey A; Cidon M; Cron RQ; De A; De Benedetti F; Ferguson I; Fishman MP; Goodman SI; Graham TB; Grom AA; Haines K; Hazen M; Henderson LA; Ho A; Ibarra M; Inman CJ; Jerath R; Khawaja K; Kingsbury DJ; Klein-Gitelman M; Lai K; Lapidus S; Lin C; Lin J; Liptzin DR; Milojevic D; Mombourquette J; Onel K; Ozen S; Perez M; Phillippi K; Prahalad S; Radhakrishna S; Reinhardt A; Riskalla M; Rosenwasser N; Roth J; Schneider R; Schonenberg-Meinema D; Shenoi S; Smith JA; Sönmez HE; Stoll ML; Towe C; Vargas SO; Vehe RK; Young LR; Yang J; Desai T; Balise R; Lu Y; Tian L; Bejerano G; Davis MM; Khatri P; Mellins ED;
Ann Rheum Dis; 2019 Dec; 78(12):1722-1731. PubMed ID: 31562126
[TBL] [Abstract][Full Text] [Related]
16. Macrophage activation syndrome and cytokine-directed therapies.
Schulert GS; Grom AA
Best Pract Res Clin Rheumatol; 2014 Apr; 28(2):277-92. PubMed ID: 24974063
[TBL] [Abstract][Full Text] [Related]
17. Application of the Yamaguchi criteria for classification of "suspected" systemic juvenile idiopathic arthritis (sJIA).
Kumar S; Kunhiraman DS; Rajam L
Pediatr Rheumatol Online J; 2012 Nov; 10(1):40. PubMed ID: 23176399
[TBL] [Abstract][Full Text] [Related]
18. Enrichment of Rare Variants of Hemophagocytic Lymphohistiocytosis Genes in Systemic Juvenile Idiopathic Arthritis.
Marques MC; Rubin D; Shuldiner E; Datta M; Schmitz E; Cruz GG; Patt A; Bennett E; Grom A; Foell D; Gattorno M; Bohnsack J; Yeung RSM; Prahalad S; Mellins E; Anton J; Len CA; Oliveira S; Woo P; Ozen S; ; Deng Z; Ombrello MJ
medRxiv; 2024 Mar; ():. PubMed ID: 38529491
[TBL] [Abstract][Full Text] [Related]
19. Patient characteristics associated with response to NSAID monotherapy in children with systemic juvenile idiopathic arthritis.
Sura A; Failing C; Sturza J; Stannard J; Riebschleger M
Pediatr Rheumatol Online J; 2018 Jan; 16(1):2. PubMed ID: 29304824
[TBL] [Abstract][Full Text] [Related]
20. Pediatric systemic juvenile idiopathic arthritis-related lung disease: Description of clinical cohort and review of management.
Swanson C; Khan EK; Cooper A; Ibarra M; Tam-Williams J
Pediatr Pulmonol; 2024 Mar; 59(3):724-733. PubMed ID: 38155594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
